PubMed

Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.

Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, Hadler J, Schaffner W, Lynfield R, Thomas AR, Li J, Campsmith M, Whitney CG, Schuchat A.

Ann Intern Med. 2006 Jan 3;144(1):1-9.PMID: 16389249 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.

Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ.

Ann Intern Med. 2000 Feb 1;132(3):182-90.PMID: 10651598 [PubMed - indexed for MEDLINE]Related articlesFree article

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

JAMA. 2005 Oct 26;294(16):2043-51.PMID: 16249418 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.

J Infect Dis. 2007 Nov 1;196(9):1346-54. Epub 2007 Oct 4.PMID: 17922399 [PubMed - indexed for MEDLINE]Related articles

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2003 May 1;348(18):1737-46.PMID: 12724479 [PubMed - indexed for MEDLINE]Related articlesFree article

Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.

Heffernan RT, Barrett NL, Gallagher KM, Hadler JL, Harrison LH, Reingold AL, Khoshnood K, Holford TR, Schuchat A.

J Infect Dis. 2005 Jun 15;191(12):2038-45. Epub 2005 May 11.PMID: 15897989 [PubMed - indexed for MEDLINE]Related articles

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2006 Apr 6;354(14):1455-63. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638. PMID: 16598044 [PubMed - indexed for MEDLINE]Related articlesFree article

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.PMID: 15665705 [PubMed - indexed for MEDLINE]Related articles

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.PMID: 15194827 [PubMed - indexed for MEDLINE]Related articles

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A.

JAMA. 2007 Apr 25;297(16):1784-92.PMID: 17456820 [PubMed - indexed for MEDLINE]Related articlesFree article

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84.PMID: 18627249 [PubMed - indexed for MEDLINE]Related articles

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.

JAMA. 2001 Apr 4;285(13):1729-35.PMID: 11277827 [PubMed - indexed for MEDLINE]Related articlesFree article

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.PMID: 17583392 [PubMed - indexed for MEDLINE]Related articles

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W.

JAMA. 2006 Apr 12;295(14):1668-74.PMID: 16609088 [PubMed - indexed for MEDLINE]Related articlesFree article

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F.

Pediatr Infect Dis J. 2001 Dec;20(12):1105-7.PMID: 11740313 [PubMed - indexed for MEDLINE]Related articles

[Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]

Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):14-21. Epub 2009 Jan 9. Spanish. PMID: 19217998 [PubMed - indexed for MEDLINE]Related articlesFree article

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ.

Pediatrics. 2004 Mar;113(3 Pt 1):443-9.PMID: 14993532 [PubMed - indexed for MEDLINE]Related articlesFree article

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.PMID: 17721369 [PubMed - indexed for MEDLINE]Related articles

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, Gay K, Jackson D, Orenstein WA, Arnold K, Schuchat A, Farley MM; Georgia Emerging Infections Program.

Lancet. 2005 Mar 5-11;365(9462):855-63.PMID: 15752529 [PubMed - indexed for MEDLINE]Related articles

Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J.

Commun Dis Intell. 2003;27(4):478-87.PMID: 15508501 [PubMed - indexed for MEDLINE]Related articles